305 results on '"Winiarski, J."'
Search Results
2. The study on the corrosion mechanism of protective ternary Zn[sbnd]Fe[sbnd]Mo alloy coatings deposited on carbon steel in 0.5 mol dm–3 NaCl solution
3. Effect of Silver Addition to LaFeO3 Perovskite on the Activity of Monolithic La1−xAgxFeO3 Perovskite Catalysts in Methane Hexane Oxidation
4. Evolution of corrosion resistance and passive film properties of Ni-Mo alloy coatings during exposure to 0.5 M NaCl solution
5. The effect of pH of plating bath on electrodeposition and properties of protective ternary Zn–Fe–Mo alloy coatings
6. Electrodeposition and characterization of Ni–Mo–ZrO2 composite coatings
7. The influence of molybdenum on the electrodeposition and properties of ternary Zn–Fe–Mo alloy coatings
8. EIS and XPS investigations on the corrosion mechanism of ternary Zn–Co–Mo alloy coatings in NaCl solution
9. The influence of molybdenum on the corrosion resistance of ternary Zn–Co–Mo alloy coatings deposited from citrate–sulphate bath
10. Corrosion resistance of chromium-free conversion coatings deposited on electrogalvanized steel from potassium hexafluorotitanate(IV) containing bath
11. Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT—two decades of longitudinal follow-up
12. Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapse
13. SIGNIFICANTLY REDUCED RISK OF SINUSOIDAL OBSTRUCTION SYNDROME OF THE LIVER IN RECENT YEARS IN PATIENTS RECEIVING BUCY PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: PH-P346
14. Health-related quality of life in adult survivors after paediatric allo-SCT
15. Neuropsychological outcome in very young hematopoietic SCT recipients in relation to pretransplant conditioning
16. Safe administration of oral BU twice daily during conditioning for stem cell transplantation in a paediatric population: a comparative study between the standard 4-dose and a 2-dose regimen
17. BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts
18. Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation
19. Long-term renal function following bone marrow transplantation
20. Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases
21. Quality of life and health in children following allogeneic SCT
22. Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease
23. Graft-versus-leukaemia effect in children: chronic GVHD has a significant impact on relapse and survival
24. Risk factors for Epstein Barr virus-related post-transplant lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: O331
25. A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation: 500 mg/m2 as a optimal total dose for conditioning
26. Pharmacokinetics of liposomal busulphan in man
27. Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor grafting
28. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia
29. Improved survival after allogeneic haematopoietic stem cell transplantation in recent years: P646
30. Changes in allogeneic haematopoietic stem cell transplantation in children during the last two decades: P578
31. Hematopoietic stem cell transplantation in severe congenital neutropenia
32. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis
33. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation
34. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein–Barr virus polymerase chain reaction
35. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections
36. EBV associated PTLD after allogeneic stem cell transplant patients
37. Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients
38. Studies on BK virus load in urine samples and graft-versus-host disease in relation to risk for development of haemorrhagic cystitis in allogeneic haematopoetic stem cell transplanted patients
39. Risk factors for development of CMV disease after allogeneic stem cell transplantation in the era of viral load monitoring
40. Infections leading to death occurring later than 6 months after allogeneic stem cell transplantation
41. Viral load as risk factor for development of CMV disease after allogeneic stem cell transplantation
42. Graft-versus-leukaemia effect in children: chronic GVHD has a significant impact on relapse and survival
43. Prevalence of antibodies to cardiolipin in chronic ITP and reactivity with platelet membranes
44. Electrodeposition and characterisation of Ni/gelatin microgels coatings.
45. Effect of Silver Addition to LaFeO3 Perovskite on the Activity of Monolithic La1−xAgxFeO3 Perovskite Catalysts in Methane Hexane Oxidation.
46. Long-term follow up of a pilot study using placenta derived decidua stromal cells for severe acute graft versus host diseases
47. Immunoglobulin binding to platelets. The effect of aggregated IgG
48. 167 Cosmetic application of a new vitamin D derivative – safety and anti-aging efficacy analysis
49. Pathways through relapses and deaths of children with acute lymphoblastic leukemia: Role of allogeneic stem cell transplantation in Nordic data
50. An electrochemical study on the influence of sodium molybdate on electrodeposition process and phase composition of ternary Zn-Ni-Mo alloy coatings.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.